Development
Ultralife Corporation
ULBI
$7.79
$0.0951.24%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 499.61% | 284.48% | 72.32% | 49.15% | -134.14% |
| Total Depreciation and Amortization | -8.18% | 1.87% | 12.82% | 26.00% | 28.94% |
| Total Amortization of Deferred Charges | 15.69% | -26.09% | -47.06% | -65.38% | -45.16% |
| Total Other Non-Cash Items | 760.49% | 593.66% | 86.45% | -135.42% | -26.56% |
| Change in Net Operating Assets | 30.65% | 39.35% | 19.12% | -1,505.15% | -558.29% |
| Cash from Operations | 125.88% | 141.84% | 121.21% | -129.20% | -191.64% |
| Capital Expenditure | 2.97% | 3.08% | 33.05% | 40.33% | 46.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.80% | 91.80% | 93.11% | 93.62% | -621.12% |
| Total Debt Issued | -74.31% | -72.92% | -81.28% | -84.03% | -- |
| Total Debt Repaid | -85.07% | -97.63% | -112.16% | -92.20% | 54.56% |
| Issuance of Common Stock | 797.41% | -67.01% | -99.38% | -70.85% | -72.25% |
| Repurchase of Common Stock | 63.64% | 95.65% | 91.75% | 89.86% | 95.07% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.04% | 46.04% | 12.28% | 12.28% | -- |
| Cash from Financing | -81.42% | -85.29% | -94.86% | -97.36% | 772.45% |
| Foreign Exchange rate Adjustments | -78.70% | -1,174.19% | -378.81% | -319.05% | -138.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 139.34% | 129.58% | 94.15% | -20.54% | -620.33% |